Less expensive but take more time to achieve target blood pressure than combination therapy.
B.
more expensive but take less time to achieve target blood pressure than combination therapy
C.
more expensive and take more time to achieve target blood pressure than combination therapy.
D.
all answers are incorrect
2.
What problem could be partially solved if doctors use a pill that combines medication?
A.
patients perception of the treatment
B.
the cost
C.
the time taken for the treatment
D.
all answers are correct
3.
What are the results of amlodipine-based treatment?
A.
It lowers blood pressure and increases cardiovascular morbidity or mortality.
B.
It lowers blood pressure and decreases incidence of myocardial infarction.
C.
It lowers blood pressure and decreases cardiovascular morbidity or mortality.
D.
It increases blood pressure but there is no decrease in cardiovascular morbidity or mortality.
4.
What is one of the disadvantages of the fixed-dose?
A.
It is difficult to adjust the dose.
B.
It is not easy to simplify the treatment.
C.
The combination of agents can be used to minimize the effects.
D.
The cost sometimes is decreased.
5.
Target blood pressure is achieved when:
A.
switching medications and improving long-term outcomes.
B.
combining lower doses of each agent.
C.
combining higher doses and switching medications.
D.
switching medications and reducing cost.
6.
JNC-7 guidelines and the American College of cardiology/American Heart Association recommend the same treatment for hypertensive patients with heart failure and hypertensive patients who have had myocardial infarction, which is:
A.
Diuretics, beta blockers, ACE inhibitors and ARBs.
B.
ACE inhibitors, ARBs, beta blockers and aldosterone
C.
Diuretics, short acting calcium channel blockers, ACE inhibitors and ARBs
D.
Beta blockers, ACE inhibitors, ARBs and short acting calcium channel blockers
7.
Which medication has similar advantages in the treatment of diabetes mellitus to control blood pressure?
A.
ACE inhibitor and calcium channel blocker
B.
ACE inhibitor and aldosterone antagonist
C.
ACE inhibitor and beta blocker
D.
ACE inhibitor and diuretics.
8.
What is the problem with monotherapy treatment when treating chronic kidney disease?
A.
The level of blood pressure lowering is hardly ever reached
B.
The level of blood pressure achieved is greater
C.
There is an increase in the progression to end-stage
